{
    "2019-01-16": [
        [
            {
                "time": "2018-01-16",
                "original_text": "格隆汇港股聚焦(1.16)︱中国平安2018年原保费收入升18.94%至7191.44亿元",
                "features": {
                    "keywords": [
                        "中国平安",
                        "2018年",
                        "原保费收入",
                        "增长",
                        "18.94%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-16",
                "original_text": "复星医药子公司治疗敏感结核病药品通过一致性评价",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "药品",
                        "一致性评价",
                        "敏感结核病"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-16",
                "original_text": "润灵全球责任评级：2018年，851家A股上市公司披露CSR报告，CSR信息披露十年增长1.29倍",
                "features": {
                    "keywords": [
                        "润灵全球责任评级",
                        "2018年",
                        "A股上市公司",
                        "CSR报告",
                        "增长",
                        "1.29倍"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "社会责任"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-16",
                "original_text": "【权益变动】复星医药(02196-HK)获复星国际增持36.55万股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复星国际",
                        "增持",
                        "36.55万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}